2(1H)-Quinolinone,8-hydroxy-5-[(1R,2S)-1-hydroxy-2-[(1-methylethyl)amino]butyl]-, hydrochloride,hydrate (2:2:1), rel-(CAS: 81262-93-3)

This compound requires adherence to GHS classification for hazardous chemicals, REACH regulations for registration, evaluation, authorization, and restriction of chemicals in the EU, and FDA/EPA guidelines for safety and environmental impact. Specific storage, handling, and transportation requirements must also be followed.

Synthetic alternatives include using related compounds like 1-methyl-2-pyrrolidinone or 2-quinolinone. Isomers and analogs such as 2(1H)-quinolinone,8-hydroxy-5-[(1S,2R)-1-hydroxy-2-[(1-methylethyl)amino]butyl]-, hydrochloride,hydrate may also be considered as substitutes.

Market trends indicate increasing research interest in this compound for its potential in pharmaceutical applications, particularly in cancer therapy. Emerging research focuses on its antimicrobial and antiviral properties. Demand is growing due to its unique chemical structure and biological activities.

Waste containing this compound should be collected in appropriate containers, labeled accordingly, and stored at controlled temperatures. Disposal should follow local regulations, often including incineration or professional waste disposal. Protective measures such as gloves and goggles must be worn during handling to avoid exposure. Environmental protection and safety precautions are critical to prevent contamination and harm.